Finding 1130355 (2024-001)

Significant Deficiency
Requirement
B
Questioned Costs
$1
Year
2024
Accepted
2025-04-03
Audit: 352552
Organization: Edison Welding Institute (OH)

AI Summary

  • Core Issue: EWI overcharged indirect costs by $26,632 to granting agencies in 2024.
  • Impacted Requirements: Indirect costs must align with the approved provisional indirect cost rates from the granting agency.
  • Recommended Follow-Up: EWI should regularly review indirect costs and ensure compliance with approved rates.

Finding Text

Assistance Listing, Federal Agency, and Program Name - Research and Development Cluster Federal Award Identification Number and Year - Various, 2024 Pass-through Entity - Various Finding Type - Significant deficiency and material noncompliance with laws and regulations Repeat Finding - No Criteria - EWI should only charge indirect costs approved in accordance with the provisional indirect cost rate approved by the cognizant granting agency. Condition - EWI overcharged indirect costs to the granting agencies by $26,632 during 2024. Questioned Costs - $26,632 If questioned costs are not determinable, description of why known questioned costs were undetermined or otherwise could not be reported - N/A Identification of How Questioned Costs Were Computed - Questioned costs were computed by using the approved indirect cost rates and comparing the indirect costs that were charged to the grants. Context - During audit procedures, all direct costs charged to the grants were reviewed and indirect costs were recalculated based on the approved provisional indirect cost rates. The calculated indirect costs were then compared to the indirect costs actually charged to the grants. The difference was computed as an amount overcharged to the grants of $26,632. Cause and Effect - EWI failed to properly review the indirect costs that were charged to the grants to ensure that indirect costs were properly applied. Recommendation - EWI should periodically review the indirect costs and the approved indirect cost rates that are actually charged to the grants. Views of Responsible Officials and Corrective Action Plan - Management agrees with the finding as reported and has taken measures to strengthen the review of indirect costs charged to the grants.

Categories

Questioned Costs Subrecipient Monitoring Significant Deficiency

Other Findings in this Audit

  • 553885 2024-001
    Significant Deficiency
  • 553886 2024-001
    Significant Deficiency
  • 553887 2024-001
    Significant Deficiency
  • 553888 2024-001
    Significant Deficiency
  • 553889 2024-001
    Significant Deficiency
  • 553890 2024-001
    Significant Deficiency
  • 553891 2024-001
    Significant Deficiency
  • 553892 2024-001
    Significant Deficiency
  • 553893 2024-001
    Significant Deficiency
  • 553894 2024-001
    Significant Deficiency
  • 553895 2024-001
    Significant Deficiency
  • 553896 2024-001
    Significant Deficiency
  • 553897 2024-001
    Significant Deficiency
  • 553898 2024-001
    Significant Deficiency
  • 553899 2024-001
    Significant Deficiency
  • 553900 2024-001
    Significant Deficiency
  • 553901 2024-001
    Significant Deficiency
  • 553902 2024-001
    Significant Deficiency
  • 553903 2024-001
    Significant Deficiency
  • 553904 2024-001
    Significant Deficiency
  • 553905 2024-001
    Significant Deficiency
  • 553906 2024-001
    Significant Deficiency
  • 553907 2024-001
    Significant Deficiency
  • 553908 2024-001
    Significant Deficiency
  • 553909 2024-001
    Significant Deficiency
  • 553910 2024-001
    Significant Deficiency
  • 553911 2024-001
    Significant Deficiency
  • 553912 2024-001
    Significant Deficiency
  • 553913 2024-001
    Significant Deficiency
  • 553914 2024-001
    Significant Deficiency
  • 1130327 2024-001
    Significant Deficiency
  • 1130328 2024-001
    Significant Deficiency
  • 1130329 2024-001
    Significant Deficiency
  • 1130330 2024-001
    Significant Deficiency
  • 1130331 2024-001
    Significant Deficiency
  • 1130332 2024-001
    Significant Deficiency
  • 1130333 2024-001
    Significant Deficiency
  • 1130334 2024-001
    Significant Deficiency
  • 1130335 2024-001
    Significant Deficiency
  • 1130336 2024-001
    Significant Deficiency
  • 1130337 2024-001
    Significant Deficiency
  • 1130338 2024-001
    Significant Deficiency
  • 1130339 2024-001
    Significant Deficiency
  • 1130340 2024-001
    Significant Deficiency
  • 1130341 2024-001
    Significant Deficiency
  • 1130342 2024-001
    Significant Deficiency
  • 1130343 2024-001
    Significant Deficiency
  • 1130344 2024-001
    Significant Deficiency
  • 1130345 2024-001
    Significant Deficiency
  • 1130346 2024-001
    Significant Deficiency
  • 1130347 2024-001
    Significant Deficiency
  • 1130348 2024-001
    Significant Deficiency
  • 1130349 2024-001
    Significant Deficiency
  • 1130350 2024-001
    Significant Deficiency
  • 1130351 2024-001
    Significant Deficiency
  • 1130352 2024-001
    Significant Deficiency
  • 1130353 2024-001
    Significant Deficiency
  • 1130354 2024-001
    Significant Deficiency
  • 1130356 2024-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
11.307 Covid-19 - Economic Adjustment Assistance $2.15M
12.300 Basic and Applied Scientific Research $1.17M
81.086 Conservation Research and Development $348,623
20.723 Phmsa Pipeline Safety Research and Development “other Transaction Agreements” $237,449
11.619 Arrangements for Interdisciplinary Research Infrastructure $154,289
81.089 Fossil Energy Research and Development $149,338
12.RD Air Force Defense Research Sciences Program $60,662
12.630 Basic, Applied, and Advanced Research in Science and Engineering $48,078
12.800 Air Force Defense Research Sciences Program $28,981
20.313 Railroad Research and Development $17,119